-
Security Type
-
Crowd SAFE
-
Min Investment
-
$100
-
Offering Date
-
September 19, 2022
-
Expected Close Date
-
January 27, 2023
-
Target Raise
-
$300.00K-$1.07M
-
No. Investors
-
588
-
Security Price
-
$1
- Number of Employees
- 0
- Cash
- $378,374
- Revenue
- $56,228
- Short Term Debt
- $2,638,260
- Cost of Goods
- $48,577
- Long Term Debt
- $150,000
- Net Income
- $-1,500,388
Company Description
We all hate flossing, especially when we are tired right before bed. The only options are painful, time-consuming, and cumbersome. What’s worse: Even those who floss usually do it ineffectively! It’s no wonder that, despite the health benefits, so many skip flossing.
Key Deal Facts
$2.5M+ in pre-orders (plus 41k individuals on email waitlist)
$950k equity capital raised
5 years of testing with advisors from the ADA, establishing efficacy
Granted utility patents, additional pending
70% of Americans do not floss — Yet. We can change that.
Projecting $16M+ revenue at 66% margin in first year of on-market sales
$6B+ market for current floss that is painful, tedious, & often ineffective
Management Team / Advisory Board Bios
Eli Packouz
Founder, CEO
Dr. Ralf Raud
Founder, CTO
Dr. Ana Mascarenhas B.D.S., Dr.P.H.
Advisor
Chair of the ADA Council on Scientific Affairs, Dr. Mascarenhas advises Instafloss on scientific testing, regulation, and industry acceptance.